SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

QNT is drawing attention after reports that Quant was selected to support The Clearing Houses on-chain money initiative, fueling bullish claims about bank adoption and the tokens limited supply. Traders are split between viewing the news as a long-term catalyst and questioning whether the deal creates meaningful demand for QNT, amid sharp swings and profit-taking.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiaks shares surged after Zenkuda and KSI-501 met primary endpoints in the Phase 3 DAYBREAK trial for wet AMD, with results showing vision outcomes non-inferior to Eylea; traders also point to a planned regulatory filing and further pipeline catalysts. The community is broadly excited about the trial results and possible short covering, while others question the drugs competitive edge and warn that the sharp rally may be vulnerable to profit-taking or future financing-related dilution.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Michael Burrys move from a Palantir short position into puts, alongside his warning that the AI bubble could burst sooner than expected, is fueling debate. Bears cite valuation and bubble concerns, while bulls dismiss Burrys view and point to Palantirs AI business and recent share-price strength.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB shares plunged after CEO CJ Desai abruptly left for a senior role at Meta, with the departure drawing extra scrutiny ahead of Investor Day. Traders are divided between calling the selloff an overreactionciting reaffirmed guidance and former CEO Dev Ittycherias return as interim chiefand worrying about leadership and strategic uncertainty.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

AstraZenecas multibillion-dollar equity investment in Summit and planned ivonescimab trial collaboration are driving attention, with traders welcoming the added funding and pharma backing. Some speculate about a future acquisition or short squeeze, while others note the deal is not a buyout and that FDA and clinical milestones remain important uncertainties.

C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, predictive analytics, and Internet of Things applications in addition to a portfolio of turn-key AI applications. It operates through the following geographical segments: North America, Europe, The Middle East, and Africa, Asia Pacific, and Rest of World. The company was founded by Thomas M. Siebel, Patricia A. House and Stephen Maurice Ward, Jr. on January 8, 2009 and is headquartered in Redwood City, CA.

C3.ai Inc - Ordinary Shares - Class A

C3.ai Inc

C3.ais latest quarterly results are driving discussion: revenue declined and its next-quarter outlook fell short of expectations, despite an adjusted loss beat, positive free cash flow and stronger bookings. Traders are split between doubts about the turnaround and cash burn, and optimism about restructuring, new customer wins and potential short covering.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

CEO Dave Ricks comments about pursuing somewhat larger acquisitions to expand Lilly beyond obesity are drawing attention, with traders discussing the potential for pipeline diversification alongside concerns about valuation and intensifying GLP-1 competition.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns quarterly earnings report is the dominant focus, with traders watching forward guidance and whether AI-driven DRAM and HBM demand can sustain tight memory supply. Bulls expect strong results, while skeptics question whether high expectations are already priced in and warn that memorys cyclical nature could bring a sell-the-news reaction; broader weakness in tech adds to the caution.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webulls sharp selloff and persistent underperformance versus Robinhood and other fintech peers dominate discussion. Traders cite insider share sales and potential dilution from an employee share plan as possible pressures, while others argue the companys fundamentals remain solid; sentiment is split between further downside and hopes for an oversold rebound, with no consensus on a definitive cause.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for the U.S. Armys ALATTIS program to develop ultra-high-voltage silicon-carbide power technology is driving attention, with traders viewing it as a validation of the companys technology and defense opportunity. Bullish posts tout a potential squeeze, while skeptics note it is a prototype program with undisclosed financial terms and no clear near-term revenue impact.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


Dinithg1

D G